Maria A Parker1, Joanna M Streck2, Stacey C Sigmon3. 1. Vermont Center on Tobacco Regulatory Science, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, USA; Department of Psychiatry, University of Vermont, 111 Colchester Avenue, Burlington, VT 05401, USA. Electronic address: maria.parker@uvm.edu. 2. Vermont Center on Tobacco Regulatory Science, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, USA; Department of Psychological Science, University of Vermont, 438 College Street, Burlington, VT 05401, USA. 3. Vermont Center on Tobacco Regulatory Science, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, USA; Department of Psychological Science, University of Vermont, 438 College Street, Burlington, VT 05401, USA; Department of Psychiatry, University of Vermont, 111 Colchester Avenue, Burlington, VT 05401, USA.
Abstract
INTRODUCTION: Smoking prevalence among adults with opioid dependence far exceeds that of the general population, and cessation outcomes in this group are one-fourth that of smokers without a substance use disorder. Understanding the reasons underlying these poor outcomes is critical for developing more effective smoking interventions in this group. Elevated baseline severity of nicotine dependence is associated with lower rates of smoking cessation over time. We examined whether nicotine dependence severity among smokers may vary as a function of opioid dependence status using nationally representative samples of adult smokers. METHODS: Data were derived from multiple years of the National Survey on Drug Use and Health (NSDUH, 2006-2014; n = 58,971). Nicotine dependence was measured by the Nicotine Dependence Syndrome Scale (NDSS) and the first item (i.e., time to first cigarette) of the Fagerström Test for Nicotine Dependence (FTND). Opioid dependence was assessed using the Diagnostic and Statistical Manual of Mental Disorders criteria. RESULTS: Opioid-dependent smokers exhibited greater severity of nicotine dependence compared to non-opioid dependent smokers, as evidenced by higher mean NDSS scores (p < 0.05). On both NDSS and FTND measures of nicotine dependence, opioid-dependent smokers were also approximately twice as likely to be dependent on nicotine than those not dependent on opioids (p's < 0.05). CONCLUSIONS: Opioid dependence is associated with increased severity and prevalence of nicotine dependence among smokers. Considering the disproportionate societal and economic burdens of smoking and smoking-related consequences in this vulnerable population, continued investigations are needed to better understand opioid-dependent individuals' poor cessation outcomes.
INTRODUCTION: Smoking prevalence among adults with opioid dependence far exceeds that of the general population, and cessation outcomes in this group are one-fourth that of smokers without a substance use disorder. Understanding the reasons underlying these poor outcomes is critical for developing more effective smoking interventions in this group. Elevated baseline severity of nicotine dependence is associated with lower rates of smoking cessation over time. We examined whether nicotine dependence severity among smokers may vary as a function of opioid dependence status using nationally representative samples of adult smokers. METHODS: Data were derived from multiple years of the National Survey on Drug Use and Health (NSDUH, 2006-2014; n = 58,971). Nicotine dependence was measured by the Nicotine Dependence Syndrome Scale (NDSS) and the first item (i.e., time to first cigarette) of the Fagerström Test for Nicotine Dependence (FTND). Opioid dependence was assessed using the Diagnostic and Statistical Manual of Mental Disorders criteria. RESULTS: Opioid-dependent smokers exhibited greater severity of nicotine dependence compared to non-opioid dependent smokers, as evidenced by higher mean NDSS scores (p < 0.05). On both NDSS and FTND measures of nicotine dependence, opioid-dependent smokers were also approximately twice as likely to be dependent on nicotine than those not dependent on opioids (p's < 0.05). CONCLUSIONS:Opioid dependence is associated with increased severity and prevalence of nicotine dependence among smokers. Considering the disproportionate societal and economic burdens of smoking and smoking-related consequences in this vulnerable population, continued investigations are needed to better understand opioid-dependent individuals' poor cessation outcomes.
Authors: Renee D Goodwin; Christine E Sheffer; Hayley Chartrand; Joanna Bhaskaran; Carl L Hart; Jitender Sareen; James Bolton Journal: Nicotine Tob Res Date: 2014-07-25 Impact factor: 4.244
Authors: Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder Journal: MMWR Morb Mortal Wkly Rep Date: 2016-11-11 Impact factor: 17.586
Authors: Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Joanna M Streck; Sarah H Heil; Stephen T Higgins; Janice Y Bunn; Stacey C Sigmon Journal: Exp Clin Psychopharmacol Date: 2018-02-01 Impact factor: 3.157
Authors: William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu Journal: Drug Alcohol Depend Date: 2018-11-26 Impact factor: 4.492
Authors: Tyler D Nighbor; Sulamunn R M Coleman; Janice Y Bunn; Michael J DeSarno; Adam L Morehead; Katherine J Tang; Diana R Keith; Shirley T Plucinski; Allison N Kurti; Ivori Zvorsky; Stephen T Higgins Journal: Exp Clin Psychopharmacol Date: 2020-02-27 Impact factor: 3.157
Authors: R Kathryn McHugh; Amy C Janes; Margaret L Griffin; Nadine Taghian; Shelly F Greenfield; Roger D Weiss Journal: Subst Use Misuse Date: 2020-02-10 Impact factor: 2.164
Authors: Cheryl Oncken; Erin L Mead; Ellen A Dornelas; Chia-Ling Kuo; Heather Z Sankey; Henry R Kranzler; Sheila Thurlow Journal: Nicotine Tob Res Date: 2020-05-26 Impact factor: 4.244
Authors: Elena Dragioti; Joaquim Radua; Marco Solmi; Celso Arango; Dominic Oliver; Samuele Cortese; Peter B Jones; Jae Il Shin; Christoph U Correll; Paolo Fusar-Poli Journal: Mol Psychiatry Date: 2022-04-28 Impact factor: 15.992
Authors: Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton Journal: Prev Med Date: 2019-05-02 Impact factor: 4.018